Bisphosphonates and Cardiac Electrophysiology: Should the Red Flag Be Raised Higher?
dc.contributor.author | Kalifa, Jérôme | en_US |
dc.contributor.author | Avula, Uma Mahesh R. | en_US |
dc.date.accessioned | 2014-05-21T18:02:51Z | |
dc.date.available | 2015-06-01T15:48:44Z | en_US |
dc.date.issued | 2014-03 | en_US |
dc.identifier.citation | Kalifa, Jérôme ; Avula, Uma Mahesh R. (2014). "Bisphosphonates and Cardiac Electrophysiology: Should the Red Flag Be Raised Higher?." Journal of Cardiovascular Electrophysiology 25(3): 307-308. | en_US |
dc.identifier.issn | 1045-3873 | en_US |
dc.identifier.issn | 1540-8167 | en_US |
dc.identifier.uri | https://hdl.handle.net/2027.42/106704 | |
dc.publisher | Wiley Periodicals, Inc. | en_US |
dc.subject.other | Bisphosphonates | en_US |
dc.subject.other | Osteoporosis | en_US |
dc.subject.other | Atrial Fibrillation | en_US |
dc.subject.other | Arrhythmia | en_US |
dc.subject.other | Ibandronate | en_US |
dc.title | Bisphosphonates and Cardiac Electrophysiology: Should the Red Flag Be Raised Higher? | en_US |
dc.type | Article | en_US |
dc.rights.robots | IndexNoFollow | en_US |
dc.subject.hlbsecondlevel | Physiology | en_US |
dc.subject.hlbsecondlevel | Internal Medicine and Specialties | en_US |
dc.subject.hlbtoplevel | Health Sciences | en_US |
dc.description.peerreviewed | Peer Reviewed | en_US |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/106704/1/jce12349.pdf | |
dc.identifier.doi | 10.1111/jce.12349 | en_US |
dc.identifier.source | Journal of Cardiovascular Electrophysiology | en_US |
dc.identifier.citedreference | Kaakeh Y, Overholser BR, Lopshire JC: Drug‐induced atrial fibrillation. Drugs 2012; 72: 1617 ‐ 1630. | en_US |
dc.identifier.citedreference | Bonilla IM, Vargas‐Pinto P, Nishijima Y, Pedraza‐Toscano A, Ho H‐T, Long VP, Belevych AE, Glynn P, Houmsse M, Rhodes T, Weiss R, Hund TJ, Hamlin RL, Gyorke S, Carnes CA: Ibandronate and ventricular arrhythmia risk. J Cardiovasc Electrophysiol, 2014; 25: 299 ‐ 306. | en_US |
dc.identifier.citedreference | Kennel KA, Drake MT: Adverse effects of bisphosphonates: Implications for osteoporosis management. Mayo Clinic Proceedings 2009; 84: 632 ‐ 638. | en_US |
dc.identifier.citedreference | Howard PA, Barnes BJ, Vacek JL, Chen W, Lai S‐M: Impact of bisphosphonates on the risk of atrial fibrillation. Am J Cardiovasc Drugs 2010; 10: 359 ‐ 367. | en_US |
dc.owningcollname | Interdisciplinary and Peer-Reviewed |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.